Disease burden of ischemic stroke predicted to continue increasing
May 19, 2023
Major contributors to increased disease burden include smoking and a diet high in sodium, as well as five metabolic factors.
AHA presents up-to-date statistics for cardiovascular disease
Jan 25, 2023
19.05 million deaths were estimated for CVD globally in 2020, representing an increase of 18.71% from 2010.
BP measurements inaccurate with undercuffing, overcuffing
Aug 07, 2023
A significantly higher BP reading was seen with use of a regular cuff among those requiring a large or extra-large cuff.
Incidence of new-onset HTN higher for COVID-19 versus influenza patients
Aug 21, 2023
Hospitalized and nonhospitalized patients with COVID-19 were more likely to develop persistent hypertension than those with influenza.
Intensive inpatient BP management not beneficial in seniors
Jun 21, 2023
The risk for adverse events increased with intensive treatment among older adults with elevated BP in the first 48 hours of hospitalization.
Disparities in stroke risk factors persist for Black adults
Aug 07, 2023
After a year of aggressive medical management, diastolic blood pressure and physical activity scores no longer differed for Blacks and non-Blacks.
Remote program beneficial for management of HTN, cholesterol
Nov 09, 2022
Significant reductions were seen in blood pressure and LDL-C at six and 12 months for patients enrolled in the remote program.
ChatGPT can mimic clinicians for ‘low-risk’ queries, study finds
By
Aaron Dorman
Jul 19, 2023
A recent study on AI’s capabilities in healthcare suggests that patients are willing to receive advice from chatbots on “low-risk” topics.
Telehealth, monitoring tech, make a meaningful difference in helping seniors with hypertension: study
By
Aaron Dorman
Feb 21, 2024
Digital health interventions make a positive impact in managing hypertension among seniors, according to a study released last week.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.